Aarti Drugs Ltd.

AARTIDRUGS

Market Cap
₹5,010 Cr.
P/E
29.22

Aarti Drugs Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

7 Yes

Positive for this company

2 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
13.95%
3yr Average
21.48%
5yr Average
20.52%
Net Profit Margin
Latest
6.12%
3yr Average
9.13%
5yr Average
8.19%
ROCE
Latest
17.56%
3yr Average
24.83%
5yr Average
23.42%
Debt to Equity
Latest
0.51
3yr Average
0.47
5yr Average
0.58
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • APIs Production Capacity (MTPA)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Brands
    Nizoral
    Customers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Aarti Drugs Ltd.
    View the discussion on ValuePickr
    AARTI DRUGS vs AARTI PHARMALABS | Which is Best? - Value Educator
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline Timeline